blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4051713

EP4051713 - IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.08.2022
Database last updated on 13.11.2024
FormerThe international publication has been made
Status updated on  10.05.2021
Most recent event   Tooltip09.11.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Corvus Pharmaceuticals, Inc.
863 Mitten Road
Suite 102
Burlingame, CA 94010 / US
[2022/36]
Inventor(s)01 / HOTSON, Andrew
863 Mitten Road, Suite 102
Burlingame, CA 94010 / US
02 / WILLINGHAM, Stephen
863 Mitten Road, Suite 102
Burlingame, CA 94010 / US
03 / MILLER, Richard, A.
863 Mitten Road, Suite 102
Burlingame, CA 94010 / US
 [2022/36]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[2022/36]
Application number, filing date20882718.802.11.2020
[2022/36]
WO2020US58555
Priority number, dateUS201962929650P01.11.2019         Original published format: US 201962929650 P
US202063014015P22.04.2020         Original published format: US 202063014015 P
US202063078792P15.09.2020         Original published format: US 202063078792 P
[2022/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021087463
Date:06.05.2021
Language:EN
[2021/18]
Type: A1 Application with search report 
No.:EP4051713
Date:07.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 06.05.2021 takes the place of the publication of the European patent application.
[2022/36]
Search report(s)International search report - published on:US06.05.2021
(Supplementary) European search report - dispatched on:EP03.04.2024
ClassificationIPC:C07K16/28, A61P31/00, C07K16/40
[2024/06]
CPC:
C07K16/2896 (EP,KR,US); A61K39/395 (EP); A61P31/00 (EP);
A61P31/14 (KR,US); A61P35/00 (KR); C07K16/40 (EP);
G01N33/56983 (KR); A61K2039/505 (EP,KR); A61K39/00 (US);
C07K2317/21 (EP); C07K2317/24 (EP); C07K2317/52 (EP);
C07K2317/524 (EP); C07K2317/55 (KR); C07K2317/56 (EP);
C07K2317/565 (EP); C07K2317/70 (EP,KR); C07K2317/71 (EP,KR);
C07K2317/76 (EP,KR,US); C07K2317/92 (KR,US); G01N2333/165 (KR);
Y02A50/30 (EP) (-)
C-Set:
A61K39/395, A61K2300/00 (EP)
Former IPC [2022/36]C07K16/28, A61P31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/36]
TitleGerman:IMMUNMODULATORISCHE ANTI-CD73-ANTIKÖRPER UND DEREN VERWENDUNGEN[2022/36]
English:IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF[2022/36]
French:ANTICORPS ANTI-CD73 IMMUNOMODULATEURS ET LEURS UTILISATIONS[2022/36]
Entry into regional phase31.05.2022National basic fee paid 
31.05.2022Search fee paid 
31.05.2022Designation fee(s) paid 
31.05.2022Examination fee paid 
Examination procedure31.05.2022Examination requested  [2022/36]
12.12.2022Amendment by applicant (claims and/or description)
08.11.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
Fees paidRenewal fee
31.05.2022Renewal fee patent year 03
15.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2017100670  (CORVUS PHARMACEUTICALS INC [US], et al);
 [X]WO2018187512  (CORVUS PHARMACEUTICALS INC [US]);
 [E]WO2022037531  (AKESO BIOPHARMA INC [CN]);
International search[Y]US2013123345  (DAVIS IAN C [US]);
 [XY]US2019077873  (GRIFFIN EMILY PICCIONE [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.